1 - 25 of 1
Number of results to display per page
TitleCreatorDescriptionIdentifier
1 Immunomodulating Therapies for Optic Neuritis and Multiple SclerosisSteven L. Galetta, MD, NYU LangoneMultiple sclerosis is the most common demyelinating disorder of the central nervous system affecting over 1 million people worldwide and 300,000 in the United States.19990317_nanos_opticnervediseasesympos_04
1 - 25 of 1